American Bitcoin (ABTC) : 3-month performance

American Bitcoin Corp. is a bitcoin accumulation platform company.

September 3, 2025: first day of trading on the Nasdaq, following a merger with Gryphon Digital Mining. The stock experienced significant volatility, opening around $8, surging to a high of $14.52, and ultimately closing at $8.04, up 16.5% for the day. 

• Parent organization: Hut 8 Corp. (NASDAQ:HUT)
• Founders: Eric Trump, Donald Trump Jr.
• Founded: March 2025
• Headquarters: Miami, Florida
• Incorporated: Delaware
• www.americanbtc.com

Bearish Put Activity:

• ABTC Weekly Dec05 1.5 puts are seeing interest with the underlying stock down 38% (volume: 9.0K, open int: 50, implied vol: ~211%, prev day implied vol: 97%). Co is expected to report earnings mid-February.

American Bitcoin Corp (ABTC) shares plunge over 50% Tuesday with multiple trading halts as Eric Trump cites pre-merger private placement share unlock driving heavy volume and steep selloff.

 

 

 

 

 

About American Bitcoin

American Bitcoin is a majority-owned subsidiary of Hut 8 focused exclusively on industrial-scale Bitcoin mining and strategic Bitcoin reserve development. The company combines Hut 8's proven mining operations, cost-efficient infrastructure development capabilities, and disciplined approach to capital allocation with Eric Trump's commercial acumen, capital markets expertise, and commitment to the advancement of decentralized financial systems. For more information, visit www.americanbtc.com.

Baird Medical (BDMD) : 3-month performance

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. 

• Sector: Healthcare
• Industry: Medical Devices
• Full Time Employees: 148
• Founded in 2012 
• Headquartered in Guangzhou, China
• https://www.bairdmed.com

IPO: October 2, 2024 via a merger vith ExcelFin Acquisition Corp. (NASDAQ: XFIN).

MBX Biosciences (MBX) : 3-month performance

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. 

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 38
• Founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018
• Headquartered in Carmel, Indiana
• https://mbxbio.com

 

SolarMax Technology (SMXT) : 3-month performance

 Ticker:  SMXT

CG Oncology (CGON) : Cretostimogene monotherapy demonstrated 75.2% complete response rate

CG Oncology announces that data from the Phase 3 BOND-003 study evaluating the efficacy and safety of cretostimogene monotherapy in patients with high-risk Non-Muscle Invasive Bladder Cancer unresponsive to Bacillus Calmette Guerin, showed that 75.2% of

patients achieved a complete response at any time, as of the cutoff date of April 1, 2024

IPO Jan 25, 24: CG Oncology (CGON) priced upsized 20.0 mln share IPO $19.00 per share, above the $16-18 expected range

The IPO was upsized from 17.0 mln shares, which was upsized from the original 11.8 mlnshares.

Ticker: CGON

• Founded: 2010
• Headquarters: Irvine, California
• Website: cgoncology.com
• Employees: 61

 

 

 

Abivax (ABVX) began trading on the Nasdaq on 20 Oct 23

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. 

 

It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. 

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 67
• Founded by Philippe Pouletty in 2003
• Headquartered in Paris, France
• https://www.abivax.com

Atlas Energy Solutions (AESI) began trading on the NYSE on Thur 9 Mar 23

Atlas Energy Solutions Inc. provides proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico. The company was .

• Sector(s): Energy
• Industry: Oil & Gas Equipment & Services
• Full Time Employees: 371
• Founded in 2017 
• HQ in Austin, Texas
• https://atlas.energy

TPG Inc. (TPG) began trading on the Nasdaq on Thur 13 Jan 22

• Holding some $109 billion in assets, Texas- and San Francisco-based TPG becomes the fifth-largest publicly traded private equity firm in the U.S. by assets, again behind Blackstone ($619 billion), Apollo ($481 billion), Carlyle ($256 billion) and KKR ($252 billion).
• Founded in 1992, TPG in November announced plans to go public and owns outsize stakes in talent agency CAA, Vice Media and Spotify. Its long-awaited debut breathes new life into private equity public listings amid a massive boom in buyout deals.

Sector(s): Financial Services

Industry: Asset Management

Full Time Employees: 1,850

https://www.tpg.com

 

Samsara (IOT) : 3-month performance

 

GlobalFoundries (GFS) began trading on the Nasdaq on Thur 28 Oct 21

GlobalFoundries, which was spun off from Advanced Micro Devices (AMD) in 2009, is the world’s third-largest foundry based on revenue. In 2020, the company reported revenue of $5.7 billion. As demand for chips surged in 2021, GlobalFoundries’ net revenue for the first half of the year was $3.04 billion, an increase of about 13% from a year earlier. Some of the company’s largest customers include several Nasdaq-listed companies, such as Qualcomm (QCOM), NXP Semiconductors (NXPI), AMD and Broadcom (AVGO).

GlobalFoundries Inc. is a multinational semiconductor contract manufacturing and design company incorporated in the Cayman Islands and headquartered in Malta, New York. 

Headquarters: Santa Clara, CA

CEO: Thomas Caulfield (Mar 9, 2018–)

Revenue: 6 billion USD (2020)

Number of employees: 15,000

Founded: March 2, 2009, Sunnyvale, CA

• IPO date: Oct. 28 
• Nasdaq’s largest U.S. IPO by proceeds raised in 2021 and the largest semiconductor IPO in its history.

Erasca (ERAS) : 3-month performance

 

TScan Therapeutics (TCRX) began trading on the Nasdaq on Fri 16 July 21

TScan Therapeutics (TCRX) has priced its IPO of ~6.7M shares of common stock at $15.00/share, for gross proceeds of $100M.

The company initially filed to offer 6.25M shares at a price range of $15-$17.

• TScan is a biopharmaceutical company focused on the development of T-cell receptor engineered T cell therapies (TCR-T) for the treatment of patients with cancer.

• The company’s lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation.

• TCRX is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

• The company plans to submit IND applications for each of TSC-100 and TSC-101 with the FDA  in Q4 2021.

EverCommerce (EVCM) began trading on the Nasdaq on Thur 1 July 21

EverCommerce Inc., together with its subsidiaries, provides integrated software-as-a-service solutions for service-based small and medium sized businesses.

The company was formerly known as PaySimple Holdings, Inc. and changed its name to EverCommerce Inc. in December 2020. 

• Sector(s): Technology
• Industry: Software—Infrastructure
• Full Time Employees: 2,300
• Incorporated in 2016 
• Headquartered in Denver, Colorado
• https://www.evercommerce.com

SentinelOne (S) : 3-month performance

 

LegalZoom.com (LZ) began trading on the Nasdaq on Wed 30 June 21

LegalZoom.com, Inc. operates an online platform for legal and compliance solutions in the United States.

• Sector(s): Industrials
• Industry: Specialty Business Services
• Full Time Employees: 1,218
• Incorporated in 1999 
• Headquartered in Glendale, California
• https://www.legalzoom.com

 

ZipRecruiter (ZIP) : 3-month performance

ZipRecruiter, Inc. operates an online marketplace that connects job seekers and employers.

• Sector:     Communication Services 
• Industry: Internet Content & Information
• Full Time Employees:     800
• Founded by Ian Siegel, Joe Edmonds, Ward Poulos, and Willis Redd in 2010
• Headquartered in Santa Monica, California
• https://www.ziprecruiter.com

ZIM Integrated Shipping Services (ZIM) : 3-month performance

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. 

As of December 31, 2024, it operated a fleet of 145 vessels, such as 130 container vessels and 15 vehicle transport vessels, as well as a network of 56 weekly lines. 

• Sector: Industrials
• Industry: Marine Shipping
• Full Time Employees: 4,850
• Founded on June 7, 1945 
• Headquartered in Haifa, Israel
• https://www.zim.com

Sigilon Therapeutics (SGTX) began trading on the Nasdaq on Fri 4 Dec 20

Sigilon Therapeutics, Inc., a preclinical stage biotechnology company, develops functional cures for patients with acute and chronic diseases. Its lead product candidate is SIG-002 to replace islet cells for the treatment of type 1 diabetes; and SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. 

• Sector(s): Healthcare
• Industry: Biotechnology
• Full Time Employees: 62
• Incorporated in 2015 
• Headquartered in Cambridge, Massachusetts
• https://sigilon.com

Upstart (UPST) reported earnings on Wed 17 March 21 (a/h)

  ** charts after earnings **

Upstart beats by $0.05, beats on revs; guides Q1 revs above consensus; guides FY21 revs above consensus

Reports Q4 (Dec) earnings of $0.07 per share, $0.05 better than the S&P Capital IQ Consensus of $0.02; revenues rose 41.9% year/year to $86.7 mln vs the $73.5 mln S&P Capital IQ Consensus.

Bank partners originated 123,396 loans across our platform in the fourth quarter of 2020, up 57% from the same quarter of the prior year.

Conversion on rate requests was 17.4% in the fourth quarter of 2020, up from 14.9% in the same quarter of the prior year.

Co issues upside guidance for Q1, sees Q1 revs of $112-$118 mln vs. $75.30 mln S&P Capital IQ Consensus. Sees adjusted net income of $13.4-$14.2 mln.

Co issues upside guidance for FY21, sees FY21 revs of approximately $500 mln vs. $359.45 mln S&P Capital IQ Consensus. Contribution Margin of approximately 41%.

Upstart agrees to acquire Prodigy Software; terms not disclosed

Upstart has entered into a definitive agreement to acquire Prodigy Software, a provider of cloud-based automotive retail software. With the acquisition of Prodigy, Upstart will accelerate its efforts to offer AI-enabled auto loans through the tens of thousands of auto dealers nationwide where the majority of auto loans are originated.

More than $2 bln in vehicle sales have been powered by Prodigy at franchised dealers from brands such as Toyota, Honda, and Ford.

The transaction is expected to close in the second quarter of calendar year 2021.

C3.ai (AI) : 3-month performance